Assessment of the effectiveness and acceptability of an online intervention for adapting well in the face of adversity, trauma, tragedy, threats or significant sources of stress

Not Applicable

Completed

• Conditions: Resilience, which is defined in this study as a dynamic mental health adaptation, which individuals are able to face and recover from significant distress or trauma.; Mental and Behavioural Disorders

• Registration Number: ISRCTN11866034
• Lead Sponsor: SilverCloud Health

Brief Summary

2020 Results article in https://pubmed.ncbi.nlm.nih.gov/33174530/ results (added 14/01/2021) 2019 Protocol article in https://doi.org/10.1016/j.invent.2019.100254 (added 01/07/2022)

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2019-03-20
• Study Completion: 2019-05-05
• Last Update Posted: 5 August 2022

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 82

Inclusion Criteria

1. Over 18 years of age
2. Registered student at the University of Dublin, Trinity College Dublin

Exclusion Criteria

1. Psychotic or bipolar disorder
2. Risk of suicide
3. Currently in psychotherapy

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
1. Resilience measured using the Connor-Davidson Resilience Scale (CD-RISC) at baseline and post-treatment (8 weeks)<br>2. Happiness measured using the Pemberton Happiness Index (PHI) at baseline and post-treatment (8 weeks)

Secondary Outcome Measures

Name	Time	Method
1. Gender, age, education, occupation, socioeconomic status, and clinical history measured using the Sociodemographic & History Questionnaire at baseline.<br>2. Depression measured using the Patient Health Questionnaire – 4 items (PHQ-4) at baseline and post-treatment (8 weeks)<br>3. Self-esteem measured using the Rosenberg Self-Esteem Scale (RSE) at baseline and post-treatment (8 weeks)<br>4. Stress measured using the Perceived Stress Scale – 4 items (PSS-4) at baseline and post-treatment (8 weeks)<br>5. Satisfaction with treatment measured using the Satisfaction with Treatment (SAT) scale at baseline and post-treatment (8 weeks)